AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02533687 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Monopolar TURP
Description: Monopolar TURP
Study NCT01670136 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 1 dose of sildenafil
Description: A single IV dose of sildenafil will be administered over 90 minutes with no greater than a 15-minute flush. Final dose to be determined based on at least the first 4 participants enrolled in Cohort 1; final dose expected to be a single dose between 0.25 and 0.5 mg/kg.
Study NCT01778270 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Body Bioimpedance Sensor
Study NCT02794623 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tinnitus masking
Description: Tinnitus masking via CI system
Study NCT03199508 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: the 3-day voiding diary
Description: The 3-day voiding diary is a medical record which need participants to fill in a table about urine volume for 2 days and 3 nights.
Study NCT03199508 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: the 7-day voiding diary
Description: The 7-day voiding diary is a medical record which need participants to fill in a table about urine volume and drinking water volume for 4 days and 7 nights.
Study NCT02855138 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: oral isotretinoin
Study NCT01573403 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DLBS2411
Description: 1 caplet of DLBS2411 @250 mg and 1 placebo caplet, once daily
Study NCT01573403 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: DLBS2411
Description: 2 caplets of DLBS2411 @250 mg, once daily
Study NCT01573403 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo DLBS2411
Description: 2 placebo caplets of DLBS2411, once daily
Study NCT04081662 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: compACT Intervention
Description: The mobile intervention in this study consists of two components: 1) self-monitoring and 2) an ACT-based microintervention.~Self-monitoring: twice daily, participants will complete self-reports of distress, depressive symptoms, and activity through the mobile app Lorevimo.~Microintervention: The microintervention will consist of one of 84 prompts that aim to target one of 6 processes targeted in ACT (contacting the present moment, defusion, acceptance, self-as-context, values, and committed action). At each time-point, participants have a 50% chance of receiving a microintervention question along with the daily self-monitoring assessments.
Study NCT02646137 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation combined with TACE
Description: Radiofrequency ablation (RFA) is an alternative therapy for HCC and liver metastases that can destroy a tumor by inducing thermal injury to the tissue through electromagnetic energy deposition
Study NCT02646137 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Microwave ablation combined with TACE
Description: Microwave ablation (MWA) is an appealing alternative therapy for HCC in which a microwave antenna is placed directly into the tumor, emitting an electromagnetic wave which agitates water molecules in the surrounding tissue, producing friction and heat, thereby inducing cell death via coagulation necrosis
Study NCT06004297 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ACL reconstruction
Description: performed arthroscopically
Study NCT06004297 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ACL reconstruction
Description: performed arthroscopically
Study NCT03197610 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: enamel matrix derivatives
Description: enamel matrix derivatives and subepithelial connective tissue grafts
Study NCT02477527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Stribild
Description: Change subjects from Atripla one tablet per day to elvitegravir/ cobicistat/ emtricitabine/ tenofovir disoproxil one tablet per day.
Study NCT02003443 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Self-Administered Acupressure
Description: The intervention involves teaching and supporting subjects to administer acupressure on themselves.
Study NCT02003443 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Self-Administered Acupressure
Description: The intervention involves teaching and supporting subjects to administer acupressure on themselves.
Study NCT02414516 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: OBP-801
Description: OBP-801 will be administered IV
Study NCT01149330 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Adapalene-BPO Gel
Description: Apply 1 gram of the investigational drug every night on whole face.
Study NCT01119443 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: PPX ER
Description: PPX ER 0.375mg - 1.5mg for 32 days totally
Study NCT02529111 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Echonavigator software
Study NCT02769429 — intervention group
Intervention type: DEVICE
Intervention: Ultrasound-guided CISB
Description: This group will receive ultrasound-guided CISB with the catheter placed on the upper trunk of the brachial plexus
Study NCT02769429 — intervention group
Intervention type: DEVICE
Intervention: nerve stimulator-guided CCPVB
Description: This group will receive landmark with nerve stimulator based needle placement and then nerve stimulator-guided CCPVB with the catheter placed on the 6th cervical spinal root
Study NCT02574559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Based Compassion Training Session: Developing Attention and Stability of Mind
Description: Completed at Week 1. Initial meditation exercises will be described and practiced to train attention skills (on breath) and create mental stability.
Study NCT02574559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Based Compassion Training Session: Cultivating Insight into the Nature of Mental Experience
Description: Completed at Week 2. Exercises to develop mindfulness will continue in order to promote mental stability and clarity.
Study NCT02574559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Based Compassion Training Session: Self-compassion
Description: Completed at Week 3: Techniques to analyze mental processes are introduced.
Study NCT02574559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Based Compassion Training Session: Cultivating Equanimity
Description: Completed at Week 4. Further analysis of mental processes.
Study NCT03162991 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Aerobic Exercise Intervention
Description: Aerobic Exercise Intervention- 12-weeks, exercise 3 non-consecutive days/week for \~30-55 minutes per exercise session.
Study NCT01394432 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PCI and Stem Cells or Placebo injections
Description: Conventional percutaneous coronary intervention after acute myocardial infarction. Harvest of bone marrow from iliac crest. Mesenchymal autologous stem cells preparation (7-10 days after PCI). LV mapping with Noga system (7-10 days after PCI). Randomization 1:1. Stem Cells or placebo implantation.
Study NCT01394432 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: PCI and Stem Cells or Placebo injections
Description: Conventional percutaneous coronary intervention after acute myocardial infarction. Harvest of bone marrow from iliac crest. Mesenchymal autologous stem cells preparation (7-10 days after PCI). LV mapping with Noga system (7-10 days after PCI). Randomization 1:1. Stem Cells or placebo implantation.
Study NCT02794038 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Soberlink Cellular Device
Description: BAC breath analyzer
Study NCT02794038 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: BACtrack S80 Pro
Description: BAC breath analyzer
Study NCT00969917 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IPI-504
Description: IPI 504 administered twice weekly at 225 mg/m2 for 2 weeks followed by 1 week off treatment
Study NCT03856892 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High Dose Yoga
Description: Participants engage in an intensive full yoga practice of hatha breath-based practices and inner meditative techniques along with body-based asana. Intensive level uses breath, management of abdomen, inner focus in all practices. The high dose of yoga is an interpretation of the Translational Model of Yoga (TMY) and Yoga Process formula, both developed in this study's cultural research: a systematized psycho-physical yoga method of Hatha Zone (HZ) focus (below-navel, exhale, inner focus), incorporating key components of practice-focus-surrender (PFS) approach and repeat-engage-trust (RET) elements.
Study NCT03856892 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Medium Dose Yoga
Description: The medium dose of yoga is a regular practice of primarily body-posture training with minimal reference to the breath, but with a longer period of time duration in training prior to intervention commencement. Participants have 5 months of pre-training before initiating the intervention.
Study NCT01628575 — intervention group
Intervention type: PROCEDURE
Intervention: PAO
Description: all patients underwent periodontal surgery for bone decortication followed by orthodontic treatment
Study NCT02581670 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: stereotactic radiation therapy (SRT)
Description: Lung and liver stereotactic radiation therapy (SRT) in oligometastatic breast cancer patients unsuitable for surgery, using VMAT RapidArc approach
Study NCT01248403 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Paclitaxel 80 mg/m2 on day 1, day 8 and day 15 of every 28-day cycle.
Study NCT01248403 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paclitaxel
Description: Paclitaxel 80 mg/m2 on day 1, day 8 and day 15 of every 28-day cycle.
Study NCT01248403 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RAD001
Description: RAD001 10mg (2 x5 mg tablets / day) d1-d28
Study NCT02966353 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ruxolitinib
Description: Ruxolitinib was supplied in 5 mg tablets to be taken orally approximately 12 hours apart (morning and night)
Study NCT00855569 — intervention group
Intervention type: DEVICE
Intervention: Stasilon
Description: Stasilon and gauze will be applied to donor site. Dressings will be collected and evaluated for amount of shed blood.
Study NCT03112395 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pio Medical Device
Description: The Pio device combines the technologies of pulse modulated magnetic fields and light emission locally applied to the wound area.
Study NCT02568163 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Non surgical periodontal treatment
Study NCT00611611 — intervention group
Intervention type: BIOLOGICAL
Intervention: fluzone
Description: once
Study NCT00611611 — intervention group
Intervention type: BIOLOGICAL
Intervention: pneumovax
Description: once
Study NCT02677532 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paracetamol
Description: 1 g every 8 hours
Study NCT02677532 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paracetamol
Description: 1 g every 8 hours
Study NCT02677532 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levobupivacaine wound infiltration
Description: Wound infiltration with 10 ml levobupivacaine 0.5%
Study NCT03277625 — intervention group
Intervention type: PROCEDURE
Intervention: modified omega-shaped single-loop
Description: A double-layer, end-to-side, duct-to-mucosa PJ using interrupted polydioxanone 5-0 suture (PDS II, Ethicon, Somerville, USA) for the outer layer and interrupted polypropylene 5-0 suture (Prolene, Ethicon, USA) for the inner layer is the standard technique during PD at our Institution. For the modified omega-shaped single-Loop reconstruction the loop between PJ and HJ is left intentionally longer at about 25-30 cm and an additional side-to-side jejunojejunal anastomosis is performed at the lowest point between the afferent and efferent loops of the HJ This intestinal anastomosis is done in a double-layer continuous PDS 5-0 suture technique. Neither sealants, nor stents are being applied at the PJ. In cases of thin walled and tiny hepatic ducts, the HJ is splinted using an externally diverted T-tube.
Study NCT02677532 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levobupivacaine epidural bolus
Description: Epidural bolus of 10 ml 0.25% levobupivacaine
Study NCT02677532 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sufentanil epidural bolus
Description: Epidural bolus of 0.15 mcg/kg sufentanil
Study NCT02677532 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Morphine
Description: Intravenous slow bolus of 10 mg morphine
Study NCT01172418 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Daclizumab
Description: Daclizumab used as part of combined induction.
Study NCT01172418 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thymoglobulin
Description: Thymoglobulin used as part of combined induction.
Study NCT01172418 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Thymoglobulin
Description: Thymoglobulin used as part of combined induction.
Study NCT01213914 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: An FDA approved continuous renal replacement device
Description: 70ml/kg/hr for treatment group for 48 hours with the following requirements:~* double lumen dialysis catheter should be placed in the internal jugular or femoral vein~* Anticoagulation will be determined by prescribing physician~* Use of 1.4 m2 or larger biocompatible synthetic hollow-fiber dialysis membrane that is changed every 24 hours~* Blood flow rate will be set to ensure a filtration fraction of no more than 25%~* Monitoring for electrolytes (specifically K+, Mg, Ca, and phos) during HVHF must be performed at least every 6 hours~* Replacement fluids will be bicarbonate-buffered with appropriate adjustments when citrate-anticoagulation is utilized~* All antibiotics will be dose adjusted for renal replacement therapy
Study NCT01213914 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Group
Description: Both groups will receive 'contemporary' care via consideration of the Burn-specific Sepsis Bundle adapted from the most recent Surviving Sepsis Campaign (SSC) (1) recommendations and specifically modified to our patient population
Study NCT00979108 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical therapy rehabilitation
Description: Mechanical cervical traction will be applied at a moderate force and adjusted based on symptom relief. In addition, subjects will be trained in cervical and postural exercises.
Study NCT00979108 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical therapy rehabilitation
Description: Subjects will be instructed in use of an over-the-door traction unit utilizing weights up to 20 pounds in sitting. In addition, subjects will be trained in neck and postural exercises.
Study NCT00979108 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physical therapy rehabilitation
Description: Subjects will be instructed in neck and postural exercises.
Study NCT00801892 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Continuous Positive Airway Pressure (CPAP)
Description: Mask worn over nose to splint open the airway with positive pressure to prevent the subject from holding their breath (apneas).
Study NCT00801892 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham- Continuous Positive Airway Pressure (Sham-CPAP)
Description: Mask worn over nose to splint open the airway with positive pressure to prevent the subject from holding their breath (apneas).
Study NCT02574559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Based Compassion Training Session: Developing Appreciation and Gratitude for Others
Description: Completed at Week 5. A reflection of all the things that bring us well-being are provided by or dependent upon other beings is encouraged.
Study NCT04150354 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cogito Companion
Description: During the course of the study, the research application (Cogito Companion) will be installed on participants' mobile phone. The application on the participants' phone will be recording data about their behavior. Participants will also be asked to complete bi-weekly surveys via the app.
Study NCT01521806 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Dietary Fiber
Description: Dietary fiber will be added to snack foods
Study NCT01521806 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Dietary Fiber
Description: Dietary fiber will be added to snack foods
Study NCT01273987 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: rONB
Description: Neobladder posterior wall suspended with round ligament of uterus after radical cystectomy in female with bladder cancer
Study NCT03177967 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sleep Restriction Therapy/Stimulus Control
Description: Sleep Restriction Therapy focuses on forcing your available sleep time into a fixed window. The sleeper sets a bedtime and wake-up time and sticks to those times closely. The time allocated for being allowed in bed is determined from an estimate of how long the patient in average has been sleeping during the night, in the week before treatment. The goal is to have the patient sleeping the entire time he or she is in bed by making this period so restricted that the patient has no chance of sleeping enough. Once this goal is achieved, the time allocated for bed can be slowly increased, for example by 15 minutes at a time. After enough iterations, an equilibrium is achieved that the patient can keep maintaining after treatment has completed.
Study NCT03177967 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Discussions about adverse cognitions about sleep
Description: Group discussions about insomnia, CBT-i treatment and it's effects
Study NCT03177967 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducative advice about how to improve sleep
Description: Learning about sleep and sleep hygiene tips. It also includes learning about stimulus control and sleep restriction.
Study NCT01610908 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The Schroth exercises treatment
Description: The Schroth approach consists of 3D scoliosis-specific exercises based on sensorimotor and kinesthetic principles. The goal of Schroth exercises is to teach patients to consciously maintain the correct posture in daily living activities in order to improve the curve, pain, and self-image. To achieve this goal, Schroth exercises focus on endurance and strength training of postural muscles. Schroth exercises also aim to improve posture motor control by repeating corrective movements with progressively less feedback and less passive support.~Dosage: 5 individual 1-hour long sessions, continued with the daily 45 minutes home exercise program. In addition, patients are required to come weekly for 1-hour long group sessions over the span of 6 months.
Study NCT01610908 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Global Postural Re-Education
Description: The 6-month supervised Global Postural Re-education intervention involves active movements and postures aimed at realigning joints, stretching shortened muscles and enhancing the contraction of antagonist muscles, thus avoiding postural asymmetry. These postures imply an active participation of the patient. Global Postural Re-education includes eight therapeutic postures, lying, sitting or standing, held for 15/20 min. each. Variously combinations are used during sessions chosen on based on the amount of pain, load capacity, age of the patient, and muscle chains to be stretched. Static and dynamic functions are also employed for about five minutes each sessions to use the recovered flexibility in functional activities Dosage: Weekly individual 1-hour long sessions, with daily 15 minutes home exercise program over 6 months.
Study NCT03949543 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Large Lunch Intervention
Description: Participants were asked to consume 60% of their daily energy requirements as lunch, between 12:30 and 13:30. Breakfast accounted for 15% of their total daily energy, a morning and evening snack for 5%. 15% was given for light meal either as dinner.
Study NCT03949543 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Large Dinner Intervention
Description: Participants were asked to consume 60% of their daily energy requirements as dinner, between 19:30 and 20:30, each day during their two dietary interventions. Breakfast accounted for 15% of their total daily energy, a morning and evening snack for 5%. 15% was given for light meal either as lunch.
Study NCT00728936 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: IMO-2125
Description: IMO-2125 is a synthetic DNA-based agonist of Toll-like receptor 9 (TLR9), TLR9 is expressed in humans in plasmacytoid dendritic cells and B cells of the immune system
Study NCT00728936 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Saline placebo
Description: saline placebo given subcutaneously
Study NCT00438464 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Finasteride
Description: Given PO
Study NCT00438464 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Given PO
Study NCT00438464 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prostatectomy
Description: Undergo prostatectomy
Study NCT00438464 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory biomarker analysis
Description: Correlative studies
Study NCT00438464 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Laboratory biomarker analysis
Description: Correlative studies